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Antimicrobial resistance (AMR) is considered a potential threat to global health. Norway have 
had a low prevalence of resistant bacteria. But in the recent years there has been an increase 
in resistant bacteria including, Escherichia coli, Klebsiella pneumoniae and Acinetobacter 
baumannii. Traditionally, clinical microbiology has used culture-based techniques to 
determine antimicrobial susceptibility and resistance profiles, but  now whole–genome 
sequencing for antibiotic susceptibility (WGS-AST) has emerged as a potential alternative.  
 
We aimed to investigate the prevalence of antimicrobial resistance genes and plasmids in WGS 
of 111 clinical Norwegian isolates of E. coli, K. pneumoniae, and A. baumannii, to identify 
correlations between phenotypic and genotypic resistance in the isolates, which are related to 
antibiotic resistance to β-lactam, aminoglycosides, fluoroquinolone, trimethoprim, 
tetracycline, and phenicol.   
 
The most occurring drug class was β-lactam antibiotic with TEM (38%) in E.coli, SHV (67%) 
in K. pneumoniae, and OXA (100%) and TEM (45%) gene families in A. baumannii. In silico 
detection of plasmids with Brooks et al database showed plasmid p2_000837 as prominent 
plasmid 12% E.coli isolates. There were four plasmids (pIB_NDM_1, p2_W5-6, 
pCHL5009T-102k-mcr3, pVir_020022)  in 2% K. pneumoniae isolates which were also shared 
with E. coli. Only one plasmid (pHZ23-1-1) was confirmed in 9% of A. baumannii isolates. 
PLSDB detected Plasmid A and plasmid 4 with the maximum percentage in E.coli (10%) and 
K. pneumoniae isolates (4%). In E. coli and K. pneumoniae, the presence of incompatibility 
groups was observed; IncFIB (64% and 27%), Col156 (74% and 27%), IncFII (43% and 15%), 
while IncHI-1B(pNDM-MAR) (12%) were present only in K. pneumoniae .  
 
A total of 75 isolates had resistance to the tested β-lactam antibiotics, out of which 63 had the 
corresponding resistance genes (ampC, SHV, CTX-M, TEM, LEN, OXA). Only 11 E.coli and 
one K. pneumoniae isolates were found to have resistance genes and the plasmids on the same 
node to confirm plasmid mediated resistance. 
 
This study demonstrates the utility of WGS in defining resistance elements and highlights the 
diversity of resistance within the selected isolates to further the diagnostics and therapeutics 
for the treatment of the relevant infections.  
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1. Introduction 
1.1 Background of Research 
Antimicrobial resistance has contributed immensely to the continuously growing concerns 
about the ineffective treatment against microbial infections (Shi et al., 2019). Overuse of 
antibiotics and insufficient therapy are the main causes of making AMR a global problem that 
leads to longer hospital stays, too costly treatments, and higher mortality rate (Elbadawi et al., 
2019). 
 
WGS is effective in tracking onward transmission of bacteria or resistance plasmid transfer 
between bacteria. WGS is also useful to identify trends in antibiotic resistance e.g. targeting 
the bacteria that are phenotypically sensitive but genotypically positive for a resistance (Köser 
et al., 2014). However, sensitivity of the populations and specificity of allelic variants, causing 
different susceptibility phenotypes, sometimes remains lower than the detection method being 
used, making it even more challenging (Lanza et al., 2018). This new approach requires novel 
microbial informatics (for development of reference databases of molecular and clinical 
metadata), new algorithms (for prediction of resistome and resistance phenotype from 
genotype), and new protocols (for global collection and sharing of high-throughput molecular 
epidemiology data) (McArthur and Wright, 2015). 
1.2 Antimicrobial Resistance (AMR) 
Bacteria are classified as antibiotic resistant when they are non-susceptible to at least one 
antibiotic class. It is estimated that resistant infections may kill one person every 3 seconds by 
the year 2050, raising the death toll worldwide to 10 million annually (Sabino et al., 2019).  
 
In late 60s, due to presence of various antibiotics, most of the infectious bacteria remained 
sensitive to a great number of antibiotics being used to treat them. Since no new clinically 
useful structures have been discovered since 1961, the emergence of antibiotic resistance has 
escalated the ineffectiveness of the treatment. The reason we see the current clonal spread of 
resistant bacteria  is because they contain the resistant gene carrying plasmids that often dump 
their genes into the bacterial chromosome. Species like A.baumannii which were never 
regarded as pathogens are now resistant to almost all the antibiotics. It has become the main 
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cause of pneumonia even in the patients who had antibiotic treatment previously (Amyes, 
2000). So, antibiotic pressure increases the sequence variability in resistance genes. To 
measure this, metagenomics is deployed now, which allows both quantitative and qualitative 
analyses of resistomes.  
1.3 Importance of Gram-negative bacteria in AMR 
Dissemination  
Escherichia coli (E.coli) is a Gram-negative, rod shaped, facultative anaerobe from the family 
Enterobacteriaceae (Allocati et al., 2013). It resides in the large intestine of warm blooded 
animals including humans in the form of commensal microflora. The diseases related to E.coli 
are enteritis (caused by enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), 
enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli 
(EIEC), and diffusely adherent E. coli (DAEC), UTI (caused by extraintestinal E. coli ExPEC), 
septicaemia (caused by ExPEC) and neonatal meningitis (caused by E. coli K1) (Kaper et al., 
2004). ). Β-lactamase (located mainly on plasmids) production in E. coli is the major mediator 
of resistance to broad spectrum of β-lactam antibiotics and multi-drug resistance (MDR) 
(Poirel et al., 2012). 
 
Klebsiella pneumoniae (K. pneumoniae) are Gram-negative, encapsulated, non motile, rod 
shaped, anaerobic bacillus from Enterobacteriaceae, found readily in human mucosal surfaces 
including gastrointestinal tract and oropharynx, which can further proliferate into tissues 
causing serious diseases like pneumoniae, sepsis, UTI, bacteraemia, meningitis, and pyogenic 
liver abscesses (Bagley, 1985; Dao et al., 2014; Paczosa and Mecsas, 2016). K. pneumonia are 
among those bacteria which are responsible for the infections difficult to be treated with 
antimicrobial therapy (Pendleton et al., 2013) because they not only are intrinsically resistant 
to many antibiotics, but have also accumulated resistance to many additional drugs (de Man 
et al., 2018). Hundreds of AMR genes have been detected in K. pneumoniae (Holt et al., 2015). 
Two of the mechanisms for resistance used in K. pneumoniae are expression of ESBLs 
(making them resistant to cephalosporins and monobactams), and production of 
carbapenamases (making them resistant to all available β-lactam antibiotics including 
carbapenems) (Pitout et al., 2015).  
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Acinetobacter baumannii (A. baumannii)  is a strictly aerobic, Gram-negative, non motile, 
nosocomial, non fermenting coccobacillus from the family Moraxellaceae (Peleg et al., 2008), 
which cause blood infections, pneumoniae, infections in soft tissues at surgical sites, Urinary 
Tract Infections (Zhao et al.), and Multi-Drug Resistance (MDR) (Harding et al., 2018; Sievert 
et al., 2013). Their genome is prone to mutation in stress, depicting the genetic flexibility to 
upregulate their natural resistance as well as acquire foreign determinants through mobile 
genetic elements (plasmids, integrons, and transposons) A.baumanni is an opportunistic 
pathogen and even pan-drug resistance phenotypes have been observed at unprecedented rate 
in recent times (Giammanco et al., 2017). Out of 33 identified genomic species of 
Acinetobacter genus (Kim et al., 2008; Nemec et al., 2009), A. baumannii, Acinetobacter 
genomic species 3 and 13TU have been considered as the most relevant species in clinical 
context (Nemec et al., 2009).  
1.4 Resistance trends of gram negative bacteria in Norway 
The World Health Organization (WHO) regards AMR a big threat to global health regardless 
of age and location. Apart from natural causes, inappropriate antibiotic prescription, and 
unhygienic conditions in hospitals are also important contributing factors to AMR threat 
(D’Costa et al., 2011). Traditionally, Scandinavia is regarded as a low incidence area for 
antibiotic resistance (Figure 1). In Norway, resistance to antibiotics is supervised by 3 systems; 
Norwegian Surveillance System for Communicable Diseases (MSIS), Norwegian 
Surveillance System for antimicrobial drug resistance (NORM/NORM-VET), and Norwegian 
Surveillance System for antimicrobial drug resistance - Veterinary Medicine (NORM/NORM-
VET, 2016) to reduce antibiotic use, raise awareness about the spread of antibiotic resistance, 
development of new antibiotics, vaccines, and better diagnostic tools.  
 
The  percentage of E. coli with ESBL causing septicaemia has a ten-fold increase in the last 
10 years and had  an increase of 6.5 per cent of all septicaemia cases caused by E. coli in 
Norway in 2016 (NORM/NORM-VET, 2016). About 2.9% and 0.3% of healthy pregnant 
women were colonised by ESBL-producing or ampC-producing E. coli respectively (Rettedal 
et al., 2015), whereas an overall ESBL 15.8% in diarrhoea patients (273 faecal samples) with 
carrier rate of  10.3% in patients with no recent travel history and 56.3% in patients with a 
history of recent travel to Asia (Jørgensen et al., 2014a; Ulstad et al., 2016).  
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Since 2015, the third generation cephalosporins (ESBL) resistant K. pneumoniae isolates has 
increased from 2.9% to 5.3% in 2017, resulting in increased use of  broad spectrum antibiotics. 
(Haug et al., 2011). National action plan on AMR in health care aims to  reduce five specified 
groups of broad spectrum antibiotics by 30% by the end of 2020 (Ministries, 2015). 
 
In Europe, Acinetobacter species have shown high resistance level (fluoroquinolones, 
aminoglycosides and carbapenems), especially in Baltic countries, Southern and South-eastern 
Europe (Prevention and Control, 2018).  
 
Figure 1: Proportion of ESBL-positive E. coli and K. pneumoniae in blood and urine in Norway. 
Retrieved from NORM/NORM-VET, 2016 
1.5 Antimicrobial Agents 
To treat diseases and prevent the risk of infection, the antimicrobial drugs either seize 
the grown of bacteria (bacteriostatic) or kill them (bactericidal) (Kohanski et al., 
2010). Antibiotics like trimethoprim (disturbe the etrahydrofolate synthesis pathway), 
tigecycline, chloramphenicol, and tetracycline (protein synthesis inhibitors) are 
among bacteriostatic (Figure 2). Bactericidal antibacterials mainly include β-lactam 
antibiotics (prevent the formation of mature peptidoglycans), colistin (disrupt cell 
membrane), aminoglycosides (prevent protein synthesis), and quinolones (prevent 
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bacterial DNA replication) (Goffin and Ghuysen, 1998; Kohanski et al., 2010; Willey 





Figure 2: Target sites of Antibiotics in bacteria. Retrieved from 
https://courses.lumenlearning.com/microbiology/chapter/mechanisms-of-antibacterial-drugs 
 
1.5.1 Β-lactam antibiotics  
β-lactam antibiotics interrupt bacterial cell-wall synthesis after they covalently bind to 
essential penicillin-binding proteins (PBPs), enzymes that are responsible for peptidoglycan 
cross-linking in both Gram-negative and Gram- positive bacteria (Bush and Bradford, 2016). 
The mechanism of β-lactam antibiotic action is explained by structural similarity between the 
β-lactam ring and the peptidoglycan building block acyl-D-alanyl-D-alanine (Tipper and 
Strominger, 1965). The covalent bond formed between β-lactam ring and an active site serine 










Figure 3: The four-member lactam ring in penicillin is highlighted in red. Retrieved from Zeng and Lin, 2013 
 
The four major groups of β-lactam antibiotics are penicillins, cephalosporins, carbapenems, 
and monobactams (Figure 4), which are involved in affecting the bacterial cell wall synthesis. 
Four generations of cephalosporins have been introduced until now.  
 
 




1.5.2 Non- Β-lactam antibiotics 
Aminoglycosides 
Aminoglycosides are potent, broad-spectrum antibiotics that bind to A-site of 16S rRNA  of 
30S ribosomal subunit where codon-anticodon accuracy is analysed, resulting in disruption of 
protein binding in aerobic, Gram-negative bacteria (Davis et al., 2010; Hermann, 2007; Krause 
et al., 2016). AGs in return are inactivated by Aminoglycoside modifying enzymes, AME 
(Garneau-Tsodikova and Labby, 2016). For example, AAC(6’) AAC(3′)-II (N-
acetyltransferases), and  aph(3’)-II, aph(3’)-III (phosphotransferases) (Tolmasky, 2000; 
Vakulenko and Mobashery, 2003).  
Tetracycline 
Tetracyclines prefer to bind with 30S bacterial ribosomal subunit, and arrest the translation of 
highly conserved 16S ribosomal RNA (rRNA) by sterically hindering the docking of  
aminoacyl-transfer RNA (tRNA) to messenger RNA (mRNA)-ribosome complex during 
elongation (Chopra and Roberts, 2001). On the other hand, the bacteria have developed three 
strategies to become resistant to tetracyclines: limiting the accessibility for teracyclines to 
ribosomes, altering the binding site of ribosomes, production of inhibiors of tetracyclines 
(Speer et al., 1992). Tetracycline resistance genes could be spread by plasmids, transposons, 
and bacteriophages (Salyers et al., 1995). The most common tetracycline resistance 
mechanism in Gram-negative bacteria is by the gnes tetA, tetB, tetC, tetD, and tetG. However, 
tetA and tetB genes are most frequently present because they encode the most frequently used 
mechanism of tetracycline resistance in enterobacteriaceae; energy-dependent efflux. (Fluit et 
al., 2001). Mutation in tet(A), tet(K), tet(M), and tet(X) tetracycline resistance proteins causes 
tigecycline resistance. It is important to note that tet(X3) and tet(X4) inactivate all 
tetracyclines, including tigecycline and the newly FDA-approved eravacycline and 
omadacycline (He et al., 2019). 
Fluoroquinolone 
First generation quinolones; nalidixic acid discovered in 1962, were followed by second 
generation with the addition of a fluorine atom at position C-6 to the quinolone nucleus, 
making them fluoroquinolones (norofloxacin, ofloxacin, pefloxacin, ciprofloxacin etc). 
Fluoroquinolones are effective against several Gram-positive bacteria, Gram-negative 
bacteria, and intracellular bacteria.   
 17 
The resistance to fluoroquinolones has emerged because of mutation in chromosomal 
quinolone targets (DNA gyrase and topoisomerase IV) and acquired resistance due to plasmid 
mediated quinolone resistance determinants (qnr, qep, aac(6’)-Ib-cr and oqxAB (Veldman et 
al., 2011). The plasmid mediated quionolone resistance genes also have the potential to 
disseminate and enhance co-selection of other AMR genes (Ewers et al., 2012). First report of 
plasmid-mediated quinolone resistance was obtained from K. pneumoniae isolates in USA 
(Kim et al., 2009). qnr proteins alter quinolone target enzymes, efflux pump activation, or 
deficiencies in outer mebrane porins to show resistance to quinolones. Qnr proteins also raise 
the frequency level at which the quinolone resistance mutants can be selected by 100-fold 
(Martínez-Martínez et al., 1998). A gene variant of aminoglycoside acetyltransferase (aac(6′)-
Ib-cr) confers reduced susceptibility to ciprofloxacin and norfloxacin by N-acetylation of 
amino nitrogen on its piperazinyl substituent. (Robicsek et al., 2006). The qnrA, qnrB and qnrS 
genes can be found in transposons and integrons located on MDR plasmids of different 
incompatibility groups, which may carry multiple resistance determinants, including ESBLs 
and carbapenemases (Strahilevitz et al., 2009).  
Phenicol 
Chloramphenicol is a very specific and potent inhibitor of protein synthesis due to its affinity 
for peptidyltransferase of 50S ribosomal subunit of 70S ribosomes, thus preventing the 
peptidyl chain elongation in Gram-positive, Gram-negative, aerobic and anaerobic bacteria. 
Bacteria produce acetyletransferases (catA, catB) or phosphotransferases (CmlA, floR) for the 
enzymatic inactivation with acetylation as a mechanism of resistance to chloramphenicol. 
(Geisel et al., 1999; Schwarz et al., 2004). Other reasons for chloramphenicol resistance are 
target site mutation or modification, decreased membrane permeability, and reduction of 
effective intracellular drug concentration due to the presence of efflux pumps.  Genes like 
cmlA and floR are the most commonly found genes for chloramphenicol resistance 
(Bissonnette et al., 1991).  
1.6 Genetic mechanisms of antimicrobial resistance 
1.6.1 Intrinsic resistance 
Apart from environmental changes like radiation, change in light or pH, the bacteria have 
intrinsic resistance too (Wellington et al., 2013). Enzymes are used in intrinsic resistance to 
destroy or modify the drug (D’Costa et al., 2011). Bacteria can also produce inhibitors 
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(acetylases, phosphorylases, and adenylase) that reduce the drug’s affinity for its the target 
sites due to steric hindrance (Munita and Arias, 2016).  
1.6.2 Mutation 
The binding sites of antimicrobials can be altered by one or more point mutations resulting in 
prevention of binding to the target by encoding abnormal target sites, which consequently 
increase the levels of resistance. Point mutations in β-lactamase genes have assisted in the 
identification of over 300 enzymes linked with a range of β-lactam antibiotic resistance 
phenotypes (Harbottle et al., 2006). 
1.6.3 Horizontal gene transfer  
Horizontal gene transfer is the ability of bacteria to exchange genes, which is responsible of 
spread and persistence of antibiotic resistance genes. There are three types of horizontal gene 
transfer; AMR gene linked with mobile genetic element, loss of gene loci in the host, and 
acquired AMR gene through genetic transfer (through transformation, transduction, 
conjugation) (Mullany et al., 2015; Pepper et al., 2018). Mobile genetic elements such as 
plasmids, transposons, integrons, and genomic islands harbour antibiotic resistance genes 
(Bennett, 2008). Many plasmids carrying resistance genes are transferred by the process of 
conjugation. Conjugation is a replicative process in which both donor and recipient cells have 
a copy of the plasmid after the process (Wilkins, 1995). Conjugative plasmids exhibit broad 
or narrow host range. In narrow range, the transfer is restricted generally to and between a 
small number of similar bacterial species. Broad range resistance plasmids are known to be 
associated with pathogens, for example, a resistance plasmid from Pseudomonas aeruginosa 
can be transferred to a wide variety of Gram-negative organisms. These mobile plasmids work 
as one of the means of acquiring resistance genes for pathogens in the environment (Bennett, 
2008). 
1.6.4 Production of β-lactamases 
Resistance to β-lactam antibiotics is frequently mediated through the production of β-
lactamase enzymes which break down β-lactam molecules. The β-lactamases bind to β-lactam 
antibiotics at a very fast deacylation rate resulting in the opening and thus inactivation of the 
β-lactam antibiotic molecule. It allows for the bacterial enzyme to return to normal functioning 
of forming peptidoglycan polymers (Søraas, 2014).  
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In the case of the Gram-positive cell, β-lactamases may either electrostatically attach with 
peptidoglycan layers or disseminate away into the extracellular environment (Figure 5). 
However, in Gram-negative bacteria, the β-lactamase is present mostly in the periplasm, but 
towards the permeability barrier, their ability to protect the bacteria is unpredictable 
(Livermore, 1995). 
 
Figure 5: β-lactamases’ position on both gram-negative (extracellular milieu) and gram-positive 
bacteria (between the outer and cytoplasmic membranes). Retrieved from 
https://www.dreamstime.com/stock-images-gram-positive-negative-bacteria-image13281714 
 
1.7 Importance of ESBLs 
ESBLs are plasmid-mediated β-lactamases that hydrolyse penicillins, cephalosporins (1st, 2nd, 
3rd Generation), and aztreonam (Jacoby and Munoz-Price, 2005), but are susceptible  to  
cefoxitin, carbapenems, and the β-lactam antibiotic inhibitors (clavulanic acid, tazobactams) 
(Bradford, 2001). The  most  frequently  encountered ESBLs  belong to  the  TEM,  SHV 
(2be),  and  CTX-M  classes (Ali et al., 2018). 
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When the amino acid substitutions around the active site of TEM-1/2 and SHV-1 β-lactamases 
started changing the configuration of the active site, the hydrolysis of  oxymino-cephalosporin 
substrates (ceftazidime, cepodoxime, ceftriaxone, cefotaxime, monobactam, aztreonam 
occurred, leading to the discovery of a total of >130 TEM-type and >50 SHV-type β-
lactamases (Kliebe et al., 1985).  
CTX-M-type β-lactamases are capable of hydrolyzing broad-spectrum oximino- β-lactam 
antibiotics (cefotaxime, ceftriaxone, aztreonam), and are inhibited by clavulanate and 
tazobactam (Tzouvelekis et al., 2000).  
Carbapenem-hydrolysing β-lactamases (carbapenemases) related to molecular class D (OXA 
enzymes) have appeared globally as the main mechanism causing this resistance. A 
phylogenetic subgroup OXA-51 has recently been found to be intrinsically present in A. 
baumannii. Since the carbapenem resistance can not be inferred from the presence of intrinsic 
OXA-51,  alleles like OXA-23,  OXA-24, and OXA-58 have been found in the A. baumannii 
isolates with acquired resistance to carbapenems (Woodford et al., 2006).  
The metallo- β-lactamases like IMP and VIM have gained clinical importance, and have 
resistance against most β-lactamases including carbapenems (Nordmann and Poirel, 2002). In 
a Greek hospital, an isolate of E.coli with imipenem resistance was also found to have VIM 
β-lactamase. (Miriagou et al., 2003). The cause of resistance to cephalosporins and 
carbapenems in A. baumannii is due to the presence of metallo  Β-lactamases like IMP and 
VIM (Thomson and Bonomo, 2005).  
OKP-A β-lactamases are chromosomal class A β-lactamases that confer resistance to 
penicillins and early cephalosporins.  
1.7.1 Classification of Extended Spectrum Β-lactamases 
Β-lactamases can be classified according to two general schemes: the Ambler molecular 
classification and the Bush-Jacoby-Medeiros functional classification system (Table 1) 
(Paterson and Bonomo, 2005). The Ambler scheme uses protein homology criterion to divide 
β-lactam antibiotics into four major classes: A, B, C and D. Class A, C and D utilize a transient 
serine acylation/deacylation at the active site. They also show structural similarities with the 
target of β-lactam antibiotics; the DD-peptidases, and therefore presumably come from the 
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same ancestral enzyme, while class B are dependent on a metal ion at the active site 
(Majiduddin et al., 2002).  
 
 
In contrast, the Bush-Jacoby-Medeiros classification groups of β-lactamases into four main 
groups and multiple subgroups according to functional similarities. Both group details are 
mentioned in the Table 1. Most ESBLs are grouped in 2be, members of which stop the 
functioning of penicillins, cephalosporins, and monobactams, and are inhibited by clavulanic 
acid (Bush et al., 1995) . 
Table 1: Main features of two general classification schemes. Retrieved from Dhillon and Clark, 2012 
1.8 Plasmid Prevalence in Enterobacteriaceae and A. baumannii 
In order to study the epidemiological relationships, classification of the plasmids needs to be 
understood (Datta, 1977). Resistance plasmids encode resistance to antimicrobials, for 
example, IncF and IncI1 plsmids are known to carry resistance genes in E. coli, S. enterica, 
K.pneumoniae and other Enterobacteriaceae (Kaper et al., 2004). Moreover, the ColE 
plasmids encoding colicins, which have killing activity against other bacteria are also 
important plasmids (Hiraga et al., 1994). 
 
Currently there are 27 Inc groups identified in Enterobacteriaceae by Plasmid Section of the 
National Collection Type Culture, Colindale, London (Carattoli, 2011; Couturier et al., 1988). 
IncFII, IncFIA, -B and -C are included in IncF group.  
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Interestingly, IncFIC is similar to IncFII, but still compatible. Sometimes, two plasmids in an 
Inc. family have distinguishable sequences, but still they appear to be incompatible (IncXI 
R485 and IncX2 R6K from IncX family). Within IncI-complex family of replicons, IncB/O 
replicons are incompatible with IncZ replicons (Jones et al., 1993), but both of them can stay 
together with IncI1, IncIγ and IncK replicons (which are incompatible with each other) 
(Praszkier and Pittard, 2005; Praszkier et al., 1991). Details of known plasmid incompatibility 
Inc. groups are given in Table 2.  
 
In A. baumannii, the blaOXA-58 and blaOXA-23 genes encoding the OXA-58 and OXA-23 
carbapenem hydrolysing oxacillinases (CHDLs) respectively, have been found in association 
with plasmids, gathered from various parts of world (Nordmann and Poirel, 2002). A. 
baumannii plasmids belong to a limited number of plasmid lineages and their structure is very 
stable, as compared to so-called mosaic plasmids. Mosaic plasmids are composed of genetic 
elements from distinct sources and they are highly dynamic in acquisition and loss of genes 






















Table 2: List of known Incompatibility Inc. Plasmids. Retrieved from Johnson and Nolan, 2009 
 
 
1.9 Diagnostic Measures against Antimicrobial Resistance 
1.9.1  Antimicrobial Susceptibility Test (AST) 
Antibiotic susceptibility testing (AST) finds a dynamic antibiotic dosage and develops a form 
of diagnostics for protection against bacterial infections. Minimum inhibitory concentrations 
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of various antimicrobial susceptibility testing (AST) are classified by various international 
agencies. The susceptibility of microorganism towards the antibiotic is interpreted as 
susceptible (S), intermediate (I) and resistant (R). Most countries follow the epidemiological 
MIC cut-offs (ECOFFS) determined by the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST, 2020) and/or the Clinical and Laboratory Standards Institute 
(CLSI, USA) (Khan et al., 2019). Presently, AST is performed using either classical manual 
methods or growth-dependent automated systems based on BMD testing. Other AST methods 
(manual and automated), commonly performed by clinical laboratories, are the conventional 
disk diffusion, agar dilution, antimicrobial gradient (e.g. the E-test, AB Biodisk) and 
automated instrumentation (Schofield, 2012).  
1.9.2 PCR 
Apart from culturing as the standard for diagnosing infection, sequence based approaches and 
quantitative PCR offer selective and sensitive way to identify a large number of Antibiotic 
Resistance Genes (ARG). However, qPCR requires a prior selection of targets which can 
overlook many important ARGs in a particular environment (Lindgreen et al., 2016; Walsh 
and Duffy, 2013), but  is helpful to capture the non-culturable section of non clinical antibiotic 
resistome. However, targeting only selected genes is not enough to characterize the intrinsic 
resistance efflux resistance mechanisms, which are controlled by many genes (Walsh and 
Duffy, 2013). 
1.9.3 Mass Spectrometry 
Mass spectrometry (MS) has been used for microbial identification in place of conventional 
identification techniques (laboratory diagnostics) (Van Veen et al., 2010). Its role in AST and 
Antibiotic Resistance Testing (ART) has emerged recently (Hrabák et al., 2012). In contrast 
to conventional AST, where the response or no response of living organisms is noted upon 
exposure to antibiotics, ART uses the presence of biomarkers proteins, carbohydrates, lipids, 
and enzymatic activity to detect specific resistance mechanism. Mass spectrometry selects 
either resistance or susceptibility of resistance of clinical isolates. So, if we know the resistance 
mechanism for carbapenemase resistance (e.g. modification in drug influx or presence of 
carbapenemases), only the second mechanism can be selected for the inhibitors (clavulanic 
acid) related to it (Nordmann et al., 2012). MS techniques like matrix-assisted laser 
desorption/ionization time-of-flight MS (MALDI-TOF MS) and  liquid chromatography-MS 
(LC-MS; in various forms) are currently in use (Welker and Van Belkum, 2019).  
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1.9.4 Whole Genome Sequencing (WGS)  
WGS  technology has made it possible to determine and evaluate the whole DNA sequence of  
a bacterium at low costs in just a few days (Punina et al., 2015). WGS not only allows in silico 
prediction of antimicrobial resistance (including resistance to compounds not routinely tested 
phenotypically), but also the early detection of outbreaks or their epidemiological 
investigation (Köser et al., 2014). Since the in silico prediction of resistance needs to be 
validated by phenotypic antimicrobial testing (Zankari et al., 2013),the combined use of 
phenotypic assays and techniques allowing the identification of genetic determinants of 
resistance can be helpful in epidemiological surveillance. Bacteria showing similar resistance 
patterns but different mechanisms can also be identified with WGS (Gordon et al., 2014). The 
unprecedented level of details of assays obtained from WGS for microbial typing and AMR 
surveillance can describe current trends and differentiate between emerging tendencies 
(Ellington et al., 2017). Moreover, Multi drug Resistance (MDR) patterns is defined with much 
greater precision with DNA sequence based surveillance as compared to phenotypic tests. The 
reason is that bioinformatics analysis goes beyond the concept of  MDR as resistance to 
compounds from three or more drug classes, as it considers the co-carriage of particular genes 
behind different MDR patterns, allelic trends, their potential for horizontal transfer, and their 
distribution by source (Magiorakos et al., 2012).  
1.10 Bioinformatic tools for WGS- based Characterization of 
Antimicrobial Resistance  
1.10.1 Sequencing Platforms 
First generation technology has remained the leading technology for decades for DNA 
sequencing (Sanger et al., 1977), using traditional shotgun technique that produced long low 
through put read sequences (500-1000 bp) at a relatively higher cost.  
 
Second generation sequencing technology was fast and high throughput, generating short 
reads  of 25-100 bp length (HiSeq from Illumina (https://www.illumina.com/.), 454 Life 
sciences from Roche (https://www.454.com/.), Solexa, and SOLiD 
(https://www.appliedbiosystems.). They were able to run over a few million reads in a single 
run with high coverage depth, cutting short the cost for DNA sequencing significantly (Butler 
and Grimme, 2010).  
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Sequencing by synthesis approach used by Illumina has made it dominate the industry in the 
recent years (Bentley et al., 2008), using fluorescently labeled reversible terminator 
nucleotides, on clonally amplified DNA templates (immobilized on acrylamide coating on the 
surface of glass flow-cell). In 2011, MiSeq was released which is suitable for smaller 
laboratories and the clinical diagnostic market (Quail et al., 2012). 
 
One of the third generation sequencing platform; PacBio (Biosciences, 2014) has enabled 
single molecule real time sequencing (SMART). Here, DNA polymerase molecules, which 
are bound to DNA template are attached to the bottom of 50nm wide wells (zeromode 
waveguides (ZMWs). Second strand is synthesized by each polymerase in the presence of   γ-
phosphate fluorescently labeled nucleotides. When the fluorescence appears with a distinctive 
pulse, it means that fluorophores attached to the nucleotides are excited by the energy 
penetrating the waveguide at the time of addition of a new base.  It produces a relatively small 
number of longer reads (> 10 kbp) as compared to a large number of short reads <200 bp like 
Illumina. However, higher cost per base, and higher sequencing error rate (15-20%) have 
limited their use in genome assembly (Schadt et al., 2010).   
 
Oxford Nanopore Technologies (ONT) MinION8 uses a new technique where native DNA 
molecules are pulled through nanoscale pores that accept only one DNA molecule at a time. 
As the DNA molecule moves through the pore, followed by sensors detecting changes in the 
ionic current produced by each passing nucleotide. This information can be visualized in a 
‘squiggle plot’ and provides the signal used for base calling. Resulting long read lengths 
significantly improve de novo genome assemblies and the detection of structural variations in 
large genomes (Deamer et al., 2016). ONT is the first technology that can deliver sequencing 
data from clinical samples in a timeframe that allows early de-escalation and refinement of 
antimicrobial treatment (Schmidt et al., 2016). 
 
Another post 2011 NGS technique; Ion Torrent PGM (personal Genome Machine) uses 
Semiconductor technology, which detects the released protons as nucleotides are incorporated 
during synthesis. On the surface of Ion Sphere particles (3-micron diameter beads), DNA 
fragments with specific adaptor sequences are linked to and then emulsion PCR amplified. 
There are proton sensing wells fabricated on a silicon wafer for the templated beads to be 
loaded on, here the sequencing starts from a specific location in the adaptor sequence. The 
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addition of all four basis is done sequentially, base of a particular type has a particular signal 
after the proton gets released proportional to the number of bases incorporated (Rothberg et 
al., 2011).  
 
1.10.2 AMR Detection Tools 
AMR gene databases with comprehensive and accurate gene record are needed to assess AMR 
prevalence. Different approaches used are BLAST (Peirano et al., 2014), Hidden Markov 
Model (HMM) (Gibson et al., 2015), nucleotide or protein based differentiation, web interface, 
or operation on local servers. The researchers have to choose between the collections of 
resistance genes for use in HMMs (Gibson et al., 2015), or collections of nucleotides or protein 
sequences of individual resistance genes or resistance related mobile elements (McArthur et 
al., 2013; Zankari et al., 2012). Some databases focus on allelic variation of house keeping 
genes and their contribution to resistance, and some focus on acquired resistance mechanisms 
(Feldgarden et al., 2019b).   
 
Another important factor to be considered is the bias of ARG databases towards 
experimentally validated genes. Thus selection of stringent cutoffs (≥ 90% per read/contig) 
though increases the probability of targeted functional genes, but it also omits environmentally 
relevant ARGs that can be more diverse. However, lowering the cutoffs to 60-80% will 
increase the false positives (Bengtsson-Palme et al., 2017).  For the ARG characterization in 
metagenomic datasets, sequencing data (e.g. Illumina) can be used either without being 
assembled or  be de novo/reference based assembled (Breitwieser et al., 2019; Knight et al., 
2018). Although de novo assembly results in data loss, and  needs higher genome coverage of 
diverse microbes with uneven taxonomic composition, it is helpful in more accurate detection 
of protein coding genes and exploration of upstream and downstream, unlike read-based 
methods (Henson et al., 2012). Moreover, with the advent of long read sequencing 
technologies (pacBio and Oxford Nanopore), the challenges offered by short read assemblies 
can be compensated by covering whole genes and even entire operons and mobile elements 
(Schatz et al., 2010). 
 
Use of paired end reads in NGS technologies has made it possible to read the DNA fragment 
from both sides. An assembler uses both the expected distance and the orientation of the reads 
when reconstructing a genome. Although paired end reads are helpful for resolving repeat 
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regions that are longer than the length of the reads, where the one not in the repeat region helps 
the other to anchor correctly, but if the sequence data does not contain paired ends that span a 
particular repeat, then it might be impossible to assemble the data unambiguously (Treangen 
and Salzberg, 2011).  
 
ResFinder is a highly cited tool among the established tools for ARG characterization in WGS 
data. It accepts both short reads and assembled genomes/contigs, using BLAST and/or KMA 
(k-mer alignment) based approaches to detect the acquired resistance, except for the resistance 
due to chromosomal mutations. To avoid ambiguous results, it is recommended to use 90% 
identity and 60% query coverage (Zankari et al., 2012).  
 
On the other hand, Comprehensive Antibiotic Resistance database (Marini et al.) is among the 
tools for ARG surveillance in metagenomics sequencing data. In CARD database, molecular 
sequences, Resistance gene identifier (RGI), and BLAST is used for the prediction of 
antimicrobial resistance genes (ARGs) in metagenomics datasets, based on homology and 
Single nucleotide Polymorphism (SNP) models. CARD is a rigorously curated collection of 
characterized, peer reviewed resistance determinants, and linked antibiotics organized by the 
Antibiotic Resistance Ontology (ARO) and AMR gene detection models. CARD contains 
more than 2000 ontologically structured protein homologues, and includes intrinsic, mutation 
driven, and acquired resistance mechanisms. (Jia et al., 2016). 
MEGARes, which is a hand curated ARG database, detects antimicrobial resistance 
determinants in large metagenomics datasets. Each protein and nucleotide has been validated 
manually with each annotation formatted in such a way that the database can be integrated into 
custom scripting easily. However, MEGARes focuses on previously published sequences, 
rather than newly discovered variants (Lakin et al., 2017).  
 
The Bacterial Antimicrobial Resistance Reference Gene Database (AMRFinder) is derived 
from β-lactamase alleles, quinolone resistance protein alleles, ResFinder, and CARD. Since 
the AMR gene nomenclature is defined by protein identity and similarity, this phenomenon is 
used as a base of AMRFinder database. Within this framework using protein based HMMs, 
can be helpful to discover potentially novel AMR genes. This database contains over 560 
AMR HMMs, and over 4579 curated AMR protein sequences to identify AMR genes from 
sequence data. Both AMR HMMs and AMR protein sequences are put together in a 
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hierarchical framework of gene families, symbols, and names in collaboration with groups like 
CARD (Feldgarden et al., 2019b).   
 
With the exception of CARD and ResFinder , most of the ARG databases lack effective and 
sustainable curation strategies  making them outdated (Lal Gupta et al., 2020).  
 
Since the best hit approach of Next Generation Sequencing produces a high rate of false 
negatives, the Machine Learning (ML) approach considers the similarity distribution of 
sequences in the ARG database, instead of only the best hit. Due to disregard of cutoffs in ML 
gene prediction, there is a  great reduction in false negatives, as well as maintaining high 
positive rate associated with traditional best hit approach by expanding the available ARGs 
individually available in the databases like CARD, ARDB, UNIPROT etc (Arango-Argoty et 
al., 2018).  
1.10.3 In Silico Plasmid Detection Tools 
Plasmids primarily contain the genes related with environmental fitness of the host, 
catabolism, and resistance (Carattoli, 2013; Zhang et al., 2011), leading them to contribute to 
horizontal gene transfer between different species (Thomas and Nielsen, 2005). However, 
assemblies generated using Illumina sequencing do not produce complete genomes, which 
affects the efforts to characterize the plasmid content of samples.  
This happens because the plasmids tend to contain repeat sequences with sizes greater than 
sequences generated by Illumina technology (Arredondo-Alonso et al., 2017).  
 
The need for in silico plasmid detection also emerged from the difficulty of plasmid DNA 
purification if they are longer than 50kbp (Smalla et al., 2015). Moreover, since the 
metagenomes usually are biased towards chromosomal content as compared to plasmids, 
many plasmid sequences remain unidentified in sequenced metagenomes, making it a complex 
process (Dib et al., 2015).  
 
Most of the in silico plasmid detection methods are aimed at recovering circular contigs from 
de Bruijn assembly graphs (Jørgensen et al., 2014b; Rozov et al., 2017). However, even if 
plasmids are assembled directly from WGS by short read sequencing platform, still they have 
repeat region sequences that prohibit complete assembly of the plasmids, and they rely on 
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laborious and computationally intensive methods (De Toro et al., 2015; Kristiansson et al., 
2011). 
 
De Bruijn graph based plasmid prediction is done by Recycler (Rozov et al., 2017) and 
PlasmidSPAdes (Antipov et al., 2016). PlasmidSPAdes first calculates the median coverage 
from the SPAdes assembly graph to estimate a chromosome coverage, then it builds a second 
assembly graph which considers only those contigs which have a read contig coverage 
differing from chromosome coverage (Antipov et al., 2016; Bankevich et al., 2012). These 
second assemblies are regarded as putative plasmids after repeat resolution by ExSPAnder 
(Prjibelski et al., 2014). However, the read contig coverage dependency of PlasmidSPADes 
makes large and low copy plasmids nearly indistinguishable from the chromosome. This 
dependency is not applied by the databases like PlasmidFinder, cBar, and MOB-suite for 
resistance analysis (Page et al., 2018b).  
 
PlasFlow is a neural network model, that is trained to separate chromosomal and plasmid 
sequences (short-length) (Vollmers et al., 2017) from different phyla by finding hidden 
structures in highly complicated biological data (Angermueller et al., 2016). A total of 9565 
FASTA sequences were used to compile it, including 1961 chromosomes and plasmids 7604 
of organisms from the kingdom Bacteria (Krawczyk et al., 2018). Unlike PlasmidSpades and 
Recycler, which output full length plasmid sequence predictions, based on their circularity or 
differential sequencing coverage, PlasFlow can predict the plasmid origin of the contigs even 
if it does not cover the whole plasmid sequence. That clarifies PlasFlow usage in the type of 
analysis that does not require full plasmid sequences with precise taxonomic information 
(Arredondo-Alonso et al., 2017; Krawczyk et al., 2018).  
 
The plasmid detection programs that try to determine the plasmid origin of contigs include 
PlasmidFinder and cBar. cBar predicts plasmid-derived sequences (using self organizing 
maps: SOMs), on the basis of genomic signatures (k-mer composition) in full length sequences 
(Zhou and Xu, 2010), while PlasmidFinder tool detects the plasmid replicons and assigns the 
query plasmids to the respective Inc.  group in Enteobacteriaceae (Orlek et al., 2017). Since 
two plasmids sharing the same replication mechanism can not co-exist within the same cell, 
the plasmids are put into different incompatibility groups (Carattoli et al., 2014). However, 
the size of PlasmidFinder database and its limitation only to Enterobacteriaceae replicons 
limits its usage for metagenomics studies. 
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In Plasmid Constellation Network (PLACNET), BLAST is used to compare sequences against 
reference databases to reconstruct plasmids through network analysis. Plasmid prediction by 
PLACNET depends on the expertise of the researchers because it needs scaffold linking and 
coverage information, replication initiator proteins (Rip) and relaxase proteins (Rel), and 
similarity of the sequences with non redundant plasmid sequences from NCBI. In addition, it 
relies on manual curation of obtained sequence clusters, which prevents its use in automatic 
annotation pipeline (Lanza et al., 2014).  
 
Another plasmid database; PLSDB has an extensive set of complete bacterial plasmids from 
the NCBI database covering records from RefSeq and INSDC (DDBJ, EMBL-EBI, and Gen- 
Bank). All the plasmids present in the database are annotated using ARG- ANNOT (Gupta et 
al., 2014), CARD (Jia et al., 2016), ResFinder (Zankari et al., 2012) and VFDB (Chen et al., 
2005), and characterized by PlasmidFinder and pMLST (Carattoli et al., 2014).  
 
A comprehensive plasmid database; Brooks et al database contains 10,892 complete plasmid 
sequences and related metadata from NCBI and all available annotated bacterial genomes. 
(Brooks et al., 2019). 
 
1.11 Aim of the study 
The aim of this study was to perform in silico detection of  AMR genes and plasmids in the 
selected WGS of Norwegian isolates from E. coli, K. pneumoniae and A. baumanii 
 
The goal was accomplished by achieving the following secondary objectives:  
 
 Annotation of de novo assembled WGS (for resistance genes and incompatibility 
groups) as well as plasmid only contigs (for plasmid detection) 
 Assessing the prevalence of most abundant ESBLs in the isolates to evaluate their 
relevance to Norwegian background of the isolates 
 Correlating genotypic antibiotic resistance with phenotypic expression for 
concordance purposes  
 Narrowing down to the same contig number for both resistance gene and plasmids in 
order to predict the presence of plasmid mediated resistance amongst the isolates 
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2. Study Design 
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3. Materials and Method 
This work is a part of the ongoing bilateral Norway-India project AMR-Diag: A Novel 
Diagnostic Tool for Sequence Based Prediction of Antimicrobial Resistance funded by the 
Research Council of Norway. 
3.1 Clinical isolates 
The sample  collection comprised of the details mentioned in Table 3. E. coli and K. 
pneumoniae samples belonged to Norwegian patients. A. baumanii samples collection was 
based on carbapenem resistance and selected according to the guidelines of the Reference 
Centre of Antimicrobial Resistance. 
 
Table 3: Details of clinical Isolates collected for the study 
 
Microorganism Source 
  Oslo University Hospital  National competence service for the detection of 
antibiotic resistance (K-Res)  
Blood  Urine  blood, pus, respiratory secretions, abdominal 
cavity fluid and spinal fluid  










4 (241-244)   
A. baumannii 
(n=11) 
    11 (sample numbers 301-311) 
 
3.2 Antimicrobial susceptibility testing (AST) 
Phenotypic antibiotic resistance profiles for the isolates were received from the fellow master 
student (Helene Bouras) working on the AMR Diag project. Briefly, antibiotic resistance was 
assessed using the Sensititre system (ThermoFischer) in the laboratories of NIPH-FHI 
(Norwegian institute for public health/Folkehelseinstitutet). The results from quality strains 
were accepted only if they were within EUCAST range of acceptance. Each isolate was 
classified as sensitive-intermediate or resistant (Alcock et al., 2020) against given antibiotics 
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according EUCAST (European Committee for Antimicrobial Susceptibility Testing of the 
European Society of Clinical) guidelines (v 10.0, January 2020). 
3.3 Whole Genome Sequencing 
All library preparations and Illumina sequencing was performed at Oslo University Hospital 
Ullevål using the MiSeq platform. The generated output was fastq files with pair-end reads of 
300 bp length. These reads were subsequently used for de novo genome assembly and 
annotation. Three isolates with <5X coverage were re-sequenced and included in the final 
dataset.   
3.4 Genome Assembly 
3.4.1 Quality Control of Illumina Outputs 
Raw sequencing paired-end reads were quality controlled using FastQC v0.11.8 (Andrews, 
2010). Using Trimmomatic  (Bolger, Lohse, & Usadel, 2014), adaptors and low-quality (with 
<15 per base quality) sequences were removed. Average quality score threshold of 25 within 
sliding window of 4 bases was set (if the average quality score over any consecutive four bases 
drops below 25, the tool will cut the leftmost position in the window and remove the rest of 
the read ). The trimmed reads were subsequently reassessed by FastQC before further analysis. 
Both FastQC and Trimmomatic were used as part of the Omics box tool 
(https://www.biobam.com/omicsbox, March 3, 2019). 
3.4.2 De novo Assembly 
Genomes were de novo assembled using SPAdes v3.13.1 (Bankevich et al., 2012) using 
default settings. Contigs < 500 bp were discarded. The command used was:  
‘~spades.py –k 21, 33, 55, 77 -1 [path to forward reads] -2 [path to reverse 
reads] –o [path to output file] 
Assemblies were assessed by QUAST v 4.6.0 (Gurevich et al.). All statistics were based on 
contigs of size   500 bp unless otherwise noted. The command used was:  
python quast.py [options] <contig_file(s)>--o <output_dir> 
 
De novo plasmid assembly from WGS in a few isolates (104, 125, 142, 211, 225, 240) was 
performed using PlasmidSpades v 3.9 with default settings (Antipov et al., 2016). The 
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resulting plasmid assemblies were further BLAST searched for plasmids. The command for 
SPADes was used with the addition ‘plasmid’ flag: 
‘~spades.py  --plasmid –k 21, 33, 55, 77 -1 [path to forward reads] -2 [path to reverse 
reads] –o [path to output file] 
3.5 Genome Annotation  
3.5.1 Genome Features Annotation 
Annotation of features with the de novo assembled genome was performed with Prokka 
(version1.12) (Seemann, 2014) using default parameters. Counts of features (Genes, CDS, 
tmRNA, tRNAs, Bases, and repeat regions) were identified along with products of the genes. 
The command used was:  
prokka<input_file.fasta> --outdir <output_directory_name> 
3.5.2 In Silico Plasmid Identification 
Presence of plasmids in Enterobacteriaceae genomes was assessed using PlasmidFinder 
(Carattoli et al., 2014) and mlPlasmids (Arredondo-Alonso et al., 2018). In the first step of the 
analysis, PlasmidFinder database was used to identify plasmid replicons after 95 % identity as 
a cutoff. 
 
Next, to improve the plasmid replicon detection and to identify all contigs representing a 
plasmid, the mlPlasmids (web interface) tool was used. The best-matching hits in each genome 
for each replicon sequence were given as output, using 0.5 as posterior probability of 
belonging to the plasmid or chromosomal class and 1000 bp being the minimum sequence 
length.  
 
Since plasmidFinder and mlPlasmids databases do not include A.baumanii genome, the 
comparison was restricted to Enterobacteriaceae. In this regard, the de novo assemblies were 
separated into plasmid and chromosomal contigs using a neural network model; PlasFlow 
(Krawczyk et al., 2018) based on the genome signatures of chromosomes and plasmids 
sequences. The resulting plasmid only sequences of all three bacteria were BLAST searched 
for the most similar/reference plasmids in Brooks et al and PLSDB databases with 95% 
identity as a cut-off. The output files were filtered with the selection of only those contigs 
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which showed over 80% contig coverage and a length between  500-100000 bp length, as the 
plasmids rarely exceed 100 kb size (Smillie et al., 2010).  
3.5.3 Resistance Gene Identification 
Since the transferrable ARGs are typically of greater concern, ResFinder (version 2.1) 
(Zankari et al., 2012), which focuses on acquired ARGs, was used for the in silico prediction 
of acquired antibiotic resistance genes in the current study. In addition, Comprehensive 
Antibiotic Resistance Database – CARD (Alcock et al., 2020) was also employed to search 
for AMR genes. Two other resistance gene databases; MEGARes and AmrFinder (done by 
Erasmas fellow: Clàudia López) along with genome annotation with Prokka (without identity 
and matching length details) were also used to extract resistance genes. Minimum 60% of gene 
length coverage and a sequence identity of 95% was used as criteria to select the genes from 
AmrFinder and MEGARes.  
 
All the BLASTN commands for both ARG databases and the plasmid databases were as 
follows: 
blastn –<query> -db <database> -outfmt ‘6 qseqid sseqid salltitles length qstart qend 
sstart send’ –perc_identity 95 –word_size 28 
3.6 Correlation Analysis 
3.6.1 Identifying Plasmids Hosting the Resistance Genes 
The prediction of location of antibiotic resistance genes and plasmids on the same contig was 
performed to confirm plasmid mediated resistance. It was accomplished by combining the 
results of resistance prediction and plasmid detection outputs. Contigs identified by 
CARD/ResFinder were tallied with those which were carrying plasmid replicons detected by 
PlasmidFinder, Brooks et al, and PLSDB. 
3.6.2 Contig Source Comparison for Plasmid Detection 
It was important to see which contig source (plasmid contigs or WGS contigs) was a better 
option to be used as an input for plasmid detection tools. For this purpose, in a few isolates 
(104, 125, 142, 211, 225, 240), WGS were assembled with PlasmidSPADes. Furthermore 
assembled plasmids for the same isolates using plasmid exclusive contigs (SPADes, PlasFlow) 
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4.1 Phenotypic Antimicrobial Resistance 
Forty-one percent of E. coli isolates were resistant to ampicillin. Resistance to ceftazidime 
(13%), trimethoprim (22%), ciprofloxacin (14%), and gentamicin (7%) was also found, as 
shown in Figure 7. Only 2 % of E. coli isolates were resistant to chloramphenicol. No 
isolates were able to grow in the presence of colistin, meropenem, and tigecycline. In 
K.pneumoniae, resistance to ampicillin (98%), trimethoprim (16%). Moreover, resistance to 
ceftazidime (13%), cefotaxime and tigecycline (11% each), ciprofloxacin and gentamicin 
(9% each) was also present. Resistance to colistin was not shown by any of the isolates. In 
A.baumannii, all 11 isolates (100%) were resistant to ciprofloxacin, and meropenem, while 
ten of them (91%) were found to be reistant to gentamicin.  
 
 
Figure 7: Prevalence (%) of resistant Ecoli (n=58), K.pneumoniae (n=42), and A.baumannii (n=11) 
strains (%)  
 
Regarding resistance patterns, 28% of E.coli isolates were not resistant to any of the antibiotics 
tested (Figure 8). Resistance to at-least one antibiotic (15%) (either of ampicillin, 
ciprofloxacin, trimethoprim, and chloramphenicol), resistance to at-least two antibiotics (10%) 
(ampicillin combined with either of gentamicin, ciprofloxacin, and trimethoprim), and 
resistance to at-least three antibiotics (4%) (ampicillin combined with either of gentamicin and 
trimethoprim, ciprofloxacin and trimethoprim, gentamicin and trimethoprim) was prevalent in 
E.coli isolates. Only 1% E.coli isolates were resistant to at-least four antibiotics (ampicillin, 



















Resistance to one antibiotic (ampicillin) was the most common in K. pneumoniae isolates 
(26%). Resistance to at-least two antibiotics (10%) (ampicillin with either of trimethoprim, 
tigecycline, and chloramphenicol), resistance to at-least three antibiotics (4%) (ampicillin with 
either tigecyline and trimethoprim, or cefotaxime and ceftazidime), resistance to at-least five 
antibiotics (2%) (ampicillin, cefotaxime, ceftazidime, ciprofloxacin, and gentamicin), 
resistance to at-least six antibiotics (1%) (ampicillin, cefotaxime, ceftazidime, 
chloramphenicol, ciprofloxacin, and gentamicin), and resistance to at-least seven antibiotics 
(1%) (ampicillin, ceftazidime, chloramphenicol, ciprofloxacin, gentamicin, tigecycline, and 
trimethoprim) was also found.  
 
In A.baumanii, 91% of the isolates were resistant to at-least 3 antibiotics (ciprofloxacin, 
gentamicin, meropenem) , and the rest (9%) were resistant to at-least two antibiotics 
(ciprofloxacin, meropenem) (Figure 8). 
 
Figure 8: Resistance profiles of all the isolates (n=111) showing resistance to antibiotics ranging from 

















































4.2 Trimming of Illumina Sequence Reads 
The pre-processing step illustrates that bases at the end of reads tend to have lower quality. 
The quality trimming step improves the read quality leading to a higher average quality 
(Figure 9 A & B).  The quality score for each base ranges from -5 to 40, and in our study, the 
reads for each sample were of highest quality (>30) between 75-225 bp and the quality dropped 
at 5'. Despite that, the overall quality of the reads remained towards high. The processing of 
reads prior to assembly removed overrepresented sequences (only 8 samples failed in 
overrepresented sequences and the rest were either passed or with warning), thus decreased 
the duplication. The sequencing resulted in sequence data comprising average 704571 
±570319 reads per file (supplementary file 10). With trimming, the number of both surviving 










Figure 9: FastQC visualization of per base sequence quality of  E. coli isolate 157 before (A) and after (B) 
trimming of adapters and low quality reads.  
 
 
Figure 10: Influence of quality-based trimming on sequencing reads. Yellow bars indicate reads after trimming. 




















Effect of trimming on number of sequence reads
Input reads Both Surviving Reads
B 
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4.3 De novo Assembly  
Trimmed sequences were de novo assembled with SPAdes (Bankevich et al., 2012). The 
contigs were further put to quality check using Quast (Gurevich et al., 2013). The results from 
the final quality assessment are shown in Table 4. 
 
Table 4: Mean ± Standard deviation of SPAdes’ de novo assembly of 58 E. coli, 41 K.pneumoneae, and 
11 Acinetobacter isolates, visualized by QUAST. All statistics were based on contigs length ≥500 bp, 
minimum alignment length of 65, and ambiguity one.  
 
 
Both E. coli and K. pneumoniae displayed average GC% ≥50, while A. baumannii had 39%.   
Nearly half of E. coli isolates (48 %) had largest contig length in the range of 500 Kbp followed 
by 31% isolates in 800 Kbp range. In K. pneumoniae, most of the isolates (26%) had contig 
length in the range of 10 Kbp followed by 17% isolates having contig length in the range of 
500 Kbp and 800 Kbp each. K. pneumoniae isolates (10% and 14%) also had contig length in 
the range of  20 Kbp and 1000 Kbp each and 50 Kbp respectively A. baumanii displayed 73 
% of A. baumannii isolates displayed length within the range of  500 Kbp followed by 18% 
and 9% isolates in the range of 100 Kbp and 50 Kbp respectively. Regarding contiguity, 12, 
18, and 3 of E.coli, K. pneumoniae, and A. baumanii isolates had number of contigs above 500 
as shown in Figure 19.  
Statistics E. coli (n=58) K. pneumoniae (n=42) A. baumannii (n=11) 
Number of contigs 
 
Largest contig (bp) 
 






































Figure 11: Graphical representation of distribution of largest contig length 
4.4 Genome Features Annotation 
Total genome size in most of the isolates ranged between 4-5 Mbp for E.coli and 
K.pneumoniae while a few isolates fell into either below 2 Mbp or above 6 Mbp 
(supplementary file 5 and Figure 18). Number of CDS in E.coli and K.pneumoniae ranged 
between 4500-5500 in most of the cases while a few isolates had below 2000  or above 6000 
genes. tmRNA were found to be either one or two in most of E.coli and K.pneumoniae isolates 
while a few had no tRNAs. Total genome size in the form of base pairs was between 4 - 4 
Mbp for 7 of A.baumanii isolates, while 4 isolates were found to be in the genome size of 
above 5 Mbp. Number of CDS in A.baumanii ranged between 3500-4000 in 7 cases, while 4 
isolates had above 5000 genes. tRna in 7 A.baumanii isolates ranged between 60-70 with 4 
isolates having  tRNA above 80. tmRNA were one in number in 10  A.baumanii isolates with 
only one isolate having two tmRNA. There were 21, 9, and 2 isolates of E.coli, K.pneumoniae, 
A.baumanii where the repeat regions were present while 37, 33, and 9 isolates of all three 
bacteria had no repeat regions. 
4.5 Prevalence of Antimicrobial Resistance Genes 
WGS sequences were screened for AMR genes in different resistance gene databases as shown 
in (Figure 12). According to the results obtained from CARD, the most occurring drug class 
in which AMR genes were detected was β-lactam.  
 
In E.coli, the most prevalent gene was TEM (38%) with other β-lactamases in small 


























































E.coli was found in 93% of the isolates. Two β-lactam representative genes LEN and OKP-A 
were not present at all. The most abundant non- β-lactamase gene found was in 28% of E. coli 
isolates i.e. aac/aph representing gentamicin followed by 16% isolates with dfr gene for 
trimethoprim resistance and 14% isolates with tet gene (tetracycline, tigecycline). 
Fluoroquinolone (qnr) and phenicol genes (cat/Cml/floR) were found in only 3% of isolates.  
 
In K.pneumoniae, the β-lactam antibiotic resistance gene with highest percentage of isolates 
was SHV (67%) while other β-lactamase resistance genes were TEM (19%), OXA (7%), LEN 
(5%), OKP-A (2%), CTX-M (7%) and ampC (5%). Non-β-lactam antibiotic resistance 
occurred mainly with the genes (aac/aph) for aminoglycoside in 26% of K.pneumoniae 
isolates, while resistance to other non-β-lactam was in 10%, 7%, 7%, and 5% isolates for 
chloramphenicol, trimethoprim, fluoroquinolone, and tetracycline/tigecycline respectively.  
 
Regarding β-lactam resistance gene prevalence in A.baumanii, the most abundant gene was 
OXA (100% isolates) followed by ampC (91% isolates)), and TEM (45% isolates)). Nine 
percent of isolates had both SHV and CTX-M. The most abundant non β-lactam gene found 
in A.baumanii was aac/aph followed by tet (55% isolates)) and chloramphenicol genes 
(cat/Cml/floR) (36% isolates). 
 
Similar gene pattern was detected by other databases (ResFinder, MEGARes, AmrFinder, and 





































        Figure 12: Relative abundance of antimicrobial resistance genes in E. coli, K. pneumoniae and A. baumannii detected using different databases
93 90 91 91 100
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4.6 AMR Database Performance Evaluation 
The comparison of AMR databases was performed, based on the values detected in at-least 
two isolates in at-least one database.  
 
CARD database detected five β-lactamases (ampC, SHV, TEM, OXA, CTX-M) along with 
genes of all other classes in E. coli.  Six β-lactamases (ampC, SHV, TEM, OXA, CTX-M, 
LEN) along with resistance genes of aminoglycoside, tetracycline, chloramphenicol, 
trimethoprim, fluoroquinolone in K. pneumoniae,  while three β-lactamases (ampC, TEM, 
OXA) along with aminoglycoside, tetracycline and phenicol genes were detected in A. 
baumannii  as shown in Figure 13 and in supplementary file 9.  
 
ResFinder detected all the genes, as did CARD. However, ResFinder did not detect ampC, as 
it was intrinsically present. In agreement with CARD and ResFinder, MEGARes detected all 
the genes except dfr and CTX-M in both E. coli and K. pneumoniae. However, it was in 
agreement with CARD in the detection of ampC in E. coli and A. baumannii. AmrFinder 
detected three non-βlactamases resistance genes (aac/aph tet, cat/Cml/floR) in all three 
bacteria. Prokka was in agreement with CARD, ResFinder, and MEGARes in the detection of 
TEM, aac/aph, tet, and CTX-M in all three bacteria. Regarding ampC, it was in agreement 
with CARD and MEGARes in E. coli and A. baumannii, while the gene SHV was only 















































































































































































































































































































































































































































































































































































AMR Database Comparison, K.pneumoniaeB
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Figure 13:. AMR database comparison on the basis of presence of resistance genes in  number of isolates by CARD, ResFinder, MEGARes, AmrFinder, and Prokka. Reported 
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AMR Database Comparison, A. baumanniiC
 49 
 
4.7 In Silico Dectection of Plasmids 
PlasmidFinder was used to detect plasmid replicons, while Brooks et al and PLSDB was also 
used to search plasmids as shown in Figure 14. Regarding plasmids detected by Brooks et al 
database, 12% of E. coli strains had plasmid p2_000837, while the rest of 11 identified 
plasmids were found in below 10% of isolates. There were four plasmids (pIB_NDM_1, 
p2_W5-6,   pCHL5009T-102k-mcr3, pVir_020022) in 2% K. pneumoniae isolates which were 
also shared with E. coli. Only one plasmid (pHZ23-1-1) was present in  9% of A. baumannii 
isolates. Unknown plasmids in all three bacteria can be viewed in supplementary file 2.  
 
PLSDB detected many plasmids in E. coli isolates including Plasmid A with the maximum 
percentage (10%) while the rest of the 20 plasmids were present in under 4% isolates. In K. 
pneumoniae, only 9 plasmids were identified with plasmid 4 in as many as 4% isolates while 
the rest of the plasmids were in less than 3 % isolates. Only plasmid A and plasmid B were 
present in both E. coli and K. pneumoniae. No identified plasmid was present in A. baumannii 
although unknown plasmids are shown in supplementary file 2.  
 
PlasmidFinder database detected 31 previously known plasmids in E. coli isolates. IncFIB 
(64%), Col156 (47%), IncFII (21%), IncFII(29) (22%), Col8282 (10%), Col(BS512) (17%) 
were prominent plasmids while the rest of the plasmids were found in below 10% of the 
isolates. In K. pneumoniae, IncFIB(K) plasmids were present in the highest percentage (27%) 
while 15% of the isolates had both IncFII(K) and Col(MG828). Moreover, Col(8282) and 
IncHI-1B(pNDM-MAR) both were present in 12% of the isolates. The rest of the plasmids 
were represented by below 10% K. pneumoniae isolates. Contigs of plasmid origin, that could 
not be assigned to one particular plasmid/plasmid class with high degree of certainty (because 































Figure 14: Plasmid Detection by multiple databases;  Brooks et al, PLSDB, and  PlasmidFinder 
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4.8 Correlation between detected resistance genes, Phenotype 
resistance profile, and plasmids 
ResFinder detects only acquired genes and ignores chromosomal mutations (Xavier et al., 
2016) wherease CARD includes chromosomal genes and mutations. Therefore resistance 
genes from CARD database were correlated with both the phenotypic resistance and the 
plasmid found in all the isolates.  
 
Table 5 shows a total of 75 isolates that had resistance to β-lactam antibiotics (ampicillin, 
cefotaxime, ceftazidime, meropenem), out of which 63 had the corresponding resistance genes 
either alone or in combination (ampC, SHV, CTX-M, TEM, LEN, OXA). ampC and the 
phenotypic resistance to β lactam antibiotics matched 34 times, and 33 times the gene ampC 
was present without the isolate displaying and phenotypic resistance. TEM was found in 36 
isolates which was complimented by 31 isolates having phenotypic resistance to β lactam 
antibiotics. SHV gene was present in 32 isolates which was again reciprocated by 31 isolates 
having phenotypic resistance to β lactam antibiotics. A total number of three isolates had CTX-
M gene which displayed resistance to β lactam antibiotics in all three isolates. LEN gene was 
present in two isolates, and out of these two only one showed resistance to β lactam. 18 isolates 
had OXA genes with 16 isolates matching the expected phenotypic resistance to β lactam 
antibiotics. A total number of 33, 30, and 39 isolates had the presence of both the resistance 
to β lactam antibiotics and different types of plasmid; Col, IncFII, and IncFIB respectively.   
 
The antibiotic resistance against aminoglycosides (gentamicin) was found in 18 isolates, and 
either of aac/aph genes was found in 17 of the respective isolates. On the other hand, 15 
isolates were found to have the genes aac/aph but no resistance phenotypically was detected. 
There were 5, 4, 6 times when the isolates had both the resistance to gentamicin and the 
plasmid Col (different types), IncFII (different types), and InFIB (different types) respectively.  
   
There were 12 dfr genes that matched with the phenotypic resistance against trimethoprim in 
20 isolates. On 14, 9, 15  occasions, the isolates had both the resistance to trimethoprim and 
the plasmid Col (different types), IncFII and InFIB (different types) respectively.  
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A sum of 23 isolates were found with  fluoroquinolone resistance (ciprofloxacin), out of which 
3 times there was a corresponding qnr gene, while 2 isolates had qnr gene without any 
phenotypic resistance to ciprofloxacin. Col (different types), IncFII (different types), and 
IncFIB (different types) plasmids in combination with ciprofloxacin resistance were found in 
6, 5, and 9 isolates.   
 
Eight isolates found with chloramphenicol resistance were being reciprocated with either of 
cat/Cml/floR genes in only two isolates, while 7 isolates had these genes but with no expressed 
resistance to chloramphenicol. There were 5, 3, and 3 isolates had Col (different types), IncFII 
(different types), and IncFIB (different types) along with chloramphenicol resistance.  
 
Five isolates had tigecycline resistance but no corresponding tet gene was present although tet 
gene was present in 19 isolates without showing resistance to tetracycline or tigecycline 
antibiotic. It occurred 4, 2, and 1 time that the isolates had Col (different types), IncFII 























Table 5: Concordance between phenotype and genotype for predictions made using a database of 
resistance determinants and the plasmids. Red color coded genes and antibiotics have concordance. 




In order to confirm the plasmid mediated resistance, contigs of plasmid origin on which AMR 
gene was also detected are shown in Table 6. IncFII (different types) plasmids were present in 
6 isolates with the resistance gene pattern; TEM, TEM/aac/aph, and TEM/aac/aph/dfr. These 
6 isolates had resistance to either ampicillin or trimethoprim or both. IncI1(Alpha) was found 
in the isolate 106 sharing the same node with TEM with phenotypic resistance to ampicillin 
and trimethoprim. In two isolates, resistance to ampicillin and trimethoprim antibiotics, and 
antibiotic resistance genes aac/aph were located on contigs assigned to  IncQ1 plasmid. Isolate 
130 exhibiting resistance towards trimethoprim, had two plasmids (pTMTA63632, 
pIB_NDM_1) sharing contigs with tet and dfr resistance genes respectively. The isolate 211 
also had 2 plasmids (IncX3, pCFSAN061772_02) sharing contigs with qnrS1, TEM, aac/aph 
resistance genes, and showing phenotypic resistance to ampicillin, cefotaxime, ceftazidime, 
























Table 6: Common nodes between resistance genes and plasmid
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              Figure 15: Graphical representation of the contigs being shared by the resistance gene and the plasmids along with their position on the contig
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When PlasmidSPAdes assembled contigs were searched for plasmids, and was compared with 
the SPAdes assemblies (PLasFlow segregated), there were only PlasmidFinder detected 
plasmids (IncFII(29), IncX3, ColpVC, IncFIB(pkPHS1), IncFII) in 104, 125, 211, and 240 
that were common between them (Table 7). Regarding database detection, isolate 104 had 
only PlasmidFinder detected plasmid, while isolate 125 and 142 had plasmids detected by all 
three databases. In isolate 211, there were plasmids detected by PlasmidFinder and PLSDB, 
and no Brooks et al plasmids were there. Contigs of plasmid origin, that could not be assigned 
to one particular plasmid/plasmid class with high degree of certainty (because of a lot of hits 
to different plasmids of different classes) can be viewed in the supplementary file 3. 
 
 
Table 7: Plasmid detection in PlasmidSPAdes assembled WGS contigs, and its comparison with                




5.1 Quality assessment of sequencing data 
As a rule of thumb, 5-10X coverage  is suggested in order to support sequence assembly and 
genome- reconstruction (Kunin et al., 2008). In this regard, only 27 out of 111 isolates had 
sequencing depth below 5X in our study. This along with range of sequencing depth can be 
viewed in  Figure 16 and Supplementary file 6. One explanation of low sequencing depth can 
be the fact that sequencing depth is influenced by errors at many stages during DNA 
processing and library preparation e.g. amplification error, DNA quality, and target region 
complexity (Jennings et al., 2017; Ma et al., 2019; Quail and Smith), and with peaks in 
sequencing error shows marked drops in coverage (Ekblom et al., 2014). Another reason for 
low sequencing depth could be that Illumina sequencing platform favours GC-balanced 
regions that have fewer reads in GC poor regions, which usually results in uneven sequencing 
depth across genome  (Sims et al., 2014). However, average GC% in E. coli (50%), and K. 
pneumoniae (56%), and A. baumannii (39%) in our study does not agree with the statement 
above. Abrupt ARG spread across different contigs can result in low coverage in some isolates 
which is responsible for discordance between ARGs detection and phenotype (Clausen et al., 
2016). In agreement to this finding, nine E. coli and K. pneumoniae isolates with low coverage 
(1X) displayed phenotypic resistance without corresponding resistance genes in our study 
(Figure 17).  
5.2 De novo Assembly 
Regarding contiguity, 12, 18, and 3 isolates of E. coli, K. pneumoniae, and A. baumannii had 
more than 500 contigs (Figure 19 and see supplementary file 4). De Bruijn graphing 
techniques like SPAdes specifically look for the exact features that repetitive elements create 
within a graph such as convergent, divergent or cyclic paths (Ricker et al., 2012), and therefore 
terminate at these repetitive elements to avoid them to be overly compressed in the final 
assembly. Since repeat regions were detected in a few isolates as shown by the high number 
of contigs (see supplementary file 5), this resulted in a more fragmented assembly for these 
isolates. However, resistance genes were found despite the fragmented assemblies in our 
study. 
 59 
5.3 AMR Database Comparison 
CARD, ResFinder, and MEGARes have been in agreement with each other in most of the 
antibiotic resistance gene detection in our study (Figure 13). On all occasions, where CARD 
database detected a resistance gene, ResFinder also did (although only HGT resistance genes, 
thus fewer variants). However, CARD remained on top for the most number of predictions 
(both acquired and mutation- based resistance genes with multiple variants). A similar study, 
related with consolidating and exploring antibiotic resistance genes data resources, has also 
proved that using whole-genome sequences and metagenomic sequencing data, CARD not 
only performed better than the rest of the databases used (ResFinder, Antibiotic Resistance 
Genes Database; ARDB, and Comprehensive β-lactamase Molecular Annotation Resource;  
CBMAR), but it also reported the most number of correct predictions  (Xavier et al., 2016). 
On the other hand, cyclical annotation graphs like the ARO (such as used by CARD) can result 
in falsely inflated counts for the conflation of assignments in sequence classification (Lakin et 
al., 2017) 
 
Apart from MEGARes, no single resource currently enables structured, comprehensive and 
statistically appropriate analysis of metagenomics data for all types of antimicrobial 
compounds, including biocides and metals (McArthur and Tsang, 2017). However, the main 
focus of MEGARes is not to be an alternative choice for CARD and ResFinder users, but  be 
available as a foundation for the development of resistome-centered analytical methods, such 
as sequence classifiers and hierarchical statistical models. However, MEGARes focuses on 
previously published sequences, rather than newly discovered variants (Lakin et al., 2017). In 
our study, MEGARes was in agreement with CARD in the detection of all the genes with the 
exception of CTX-M and dfr. Another study compared ARG-miner and MEGARes with 
CARD, and these databases didn’t accurately detect all mutants that were detected by CARD, 
suggesting CARD is better suited for detecting chromosomal mutations compared to other 
available databases. Moreover, due to different nomenclature strategies, some discrepancies 
have been noted in ARG annotation whith MEGARes as compared to CARD, where just the 
name of the gene appeared and not the variant number (Lal Gupta et al., 2020).  
 
Although AMRFinder did not detect any β-lactamase resistance gene, and detected only three 
non-β-lactamase antibiotic resistance genes (aminoglycoside, tetracycline, chloramphenicol), 
it was in agreement with CARD, ResFinder, and MEGARes. In this regard, it is important to 
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note that AMRFinder does not attempt to assert the effects of detected proteins found to have 
a clinical resistance phenotype too, as the factors responsible for the expression of those 
proteins are outside the current coverage of AMRFinder (Feldgarden et al., 2019b). Moreover, 
gene symbol output disagreement (8.8%) was also noted between 2017 version of ResFinder 
and AMRFinder.  Since HMM and BLAST-based approaches are used by AMRFinder and 
ResFinder, both approaches need to be synchronized to minimize inconsistent outputs due to 
algorithmic differences (Feldgarden et al., 2019a).  However, HMM approaches may have 
poor specificity, producing high number of false positive predictions and sometimes may not 
be able to distinguish between ARGs with closely related functions (Lal Gupta et al., 2020). 
5.4 Phenotypic-Genotypic Relationship  
In our study,  E. coli isolates showed 56% cumulative resistance to three β-lactam antibiotics 
(ampicillin and cefotaxime, ceftazidime), followed by trimethoprim (22%), and 
fluoroquinolone (14%), while resistance to aminoglycosides, and chloramphenicol was low 
(7%, 2% respectively) ( 
Figure 7). This β-lactam antibiotic resistance phenotype is complemented by isolates having 
β-lactamase genes; ampC (93%), TEM (38%), SHV (5%), OXA (7%),VIM (2%), and CTX-
M (3%) in E. coli (Table 5 and Figure 12). Low percentage (9%) of E. coli isolates being 
resistant to gentamicin in our study is in contrast to a study where 69% (total 44 isolates) of 
ESBL producing E. coli bacteria were resistant to gentamicin  (Ojdana et al., 2018). However, 
it complies with the finding in Norway where the gentamicin non- susceptibility among the E. 
coli (109 isolates) was 4% in the isolates collected in 2009 (Lindemann et al., 2012). One 
explanation of low resistance to gentamicin in our study can be the clinical use of 
aminoglycosides below 10% of sales (total 5,450 kg) of antibiotics since 2016 in Norway 
(NORM/NORM-VET, 2016). Trimethoprim resistance rate in E. coli isolates (22%) in our 
study was comparable to 14.1% in ECO.SENS study (Kahlmeter, 2003), and 18-26% E. coli 
isolates from human clinical samples in Lithuania (Šeputienė et al., 2010).  
 
In K. pneumoniae, β-lactam antibiotic resistance was mainly towards ampicillin (98%), 
ceftazidime (13%), and cefotaxime (11%), as compared to non β-lactam antibiotics;  
trimethoprim (16%), tigecycline (11%), ciprofloxacin and gentamicin (9% each). K. 
pneumoniae isolates being resistant to gentamicin (9%) in this study are similar to the 5% (11 
isolates) in the west Norwegian K. pneumoniae isolates (Ambaye et al., 1997).  
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High percentage of phenotypic ampicillin resistance was shown in our study (E. coli 41% and 
K. pneumoniae 91%). Similar results were found in a study, where E. coli isolated from 
outpatient population (urine samples) in Bosnia and Herzegovina showed the highest 
antimicrobial resistance to ampicillin (82.79%) (Vranic and Uzunovic, 2016). Moreover, 
100% ampicillin resistant isolates of both E. coli and K. pneumoniae (urine) were obtained in 
another study from India, where E. coli and K. pneumoniae comprised 60% and 15% of total 
20 identified microorganisms (Agarwal et al., 2015). One reason of such high ampicillin 
resistance could be the high rate of penicillin (both β-lactamase sensitive and extended-
spectrum) prescription as human medicine in Norway (NORM/NORM-VET, 2016).  
 
Multi Drug Resistance (MDR) means the ability of the microorganism to resist at least one 
drug from three different antimicrobial classes (Magiorakos et al., 2012). In our study, E. coli 
was found to have MDR in 5 isolates (9%). The resistance patterns was towards three (isolate 
105, 124, 138, 112) and four (isolate 121) antibiotics. This is in contrast to many other studies, 
for example a higher percent (33.2%) of E. coli isolates were reported to be MDR in another 
study in North-western Libya (Abujnah et al., 2015).  
 
In ten isolates (24%) of K. pneumoniae, MDR phenotype was expressed with the resistance to 
three (215, 217, 225), four (220, 226), five (216), and six (211, 212, 213, 240) antibiotics 
respectively. In a similar study, higher percentage of MDR resistant K. pneumoniae (46% of 
116 isolates) was observed (Moini et al., 2015). Moreover, presence of complimentary β-
lactamase resistance genes (ampC, SHV, TEM, OXA, LEN, OKP, CTXM) supports the high 
β-lactam antibiotic resistance found in K. pneumoniae, where SHV and TEM together were 
represented by 86% of the isolates, making them the dominant β-lactamases antibiotic 
resistance genes in K. pneumoniae (Table 5 andFigure 12).  
 
Like E. coli and K. pneumoniae, A. baumannii  also displayed MDR; ciprofloxacin, 
gentamicin, and meropenem in 10 isolates (91%). Similar finding was observed in a study 
where 78 (80%) out of 97 A. baumannii clinical isolates were resistant to three or more classes 
of antimicrobial compounds, and thus considered MDR (Taitt et al., 2014). The most common 
mechanism responsible for carbapenem resistance in A. baumannii is mediated by the acquired 
oxacillinases OXA-23-like, OXA-24-like, OXA-58-like, OXA-143-like and OXA-235. 
Metallo-βlactamases, such as VIM have only rarely been found in A. baumannii (Krizova et 
al., 2012). In this regard, we found OXA-23 in nine A. baumanii isolates (302, 303, 304, 306, 
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307, 308, 309, 310, 311), OXA-24 in one (305), OXA-58 in one (301), while OXA-235 along 
with VIM enzyme was not found in any of the isolates. 
 
In our study, isolates with resistance phenotypes with no AMR genes were identified, as were 
the isolates with susceptible phenotypes that carried resistance genes (Table 5). The resistance 
phenotypes without the corresponding genes included ciprofloxacin (E. coli: 8, K. 
pneumoniae: 2 ), trimethoprim (E. coli: 4, K. pneumoniae: 4 ), chloramphenicol (E. coli: 2, K. 
pneumoniae: 5), gentamicin (E. coli: 2), and ciprofloxacin in all eleven A. baumannii isolates. 
So was the case with another study, where every antimicrobial outcome had some isolates with 
a resistant phenotype, but no genetic explanation (Rosengren et al., 2009). On the other hand, 
the susceptible phenotypes with AMR genes in E. coli included β-lactamase (ampC in 32 
isolates, TEM in 4 isolates, and OXA in 1 isolate), gentamicin (aac/aph in10 isolates), 
tetracycline (tet in 9 isolates), fluoroquinolone (qnr in 2 isolates), and phenicol (cat in 2 
isolates).  
 
In K. pneumoniae, the susceptible phenotypes with AMR genes were aminoglycosides 
(aac/aph in 5 isolates), fluoroquinolone and βlactam (qnr and LEN in one isolate each), and 
tetracycline (Nordmann et al.) and phenicol (cat/Cml/floR) in 2 isolates each.  
 
In case of A. baumannii, tetracycline, aminoglycosides and phenicol related susceptibilities 
were found with AMR genes (tet, aph, and cat/Cml/floR genes in six, one and three isolates).  
 
Another study, where E. coli genotypic resistance was compared with phenotype (Do 
Nascimento et al., 2017), reported discrepancies mainly referring to phenotypically-
susceptible isolates harbouring a resistance gene. This evident contradiction of susceptible 
isolates carrying resistance genes can be because of unexpressed resistance genes, if they are 
far from or associated with a weak promoter in an integron. Similarly, the free gene cassettes, 
which are not a part of an integron are silent because the integron’s promoter is required for 
expression (Carattoli, 2001). Alternatively, isolates could be wrongly represented as 
susceptible, if the MIC breakpoint is higher than the resistance communicated by the gene 
(Boerlin et al., 2005).  
 
Three different enzymes, CTX-M-15, -16, -19 and, recently, CTX-M-27 have been reported 
to be linked with ceftazidime hydrolysis (Bonnet et al., 2001). This is in agreement with our 
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finding where three K. pneumoniae isolates (213, 216, 220) had CTX-M gene as well as 
phenotypic resistance to ceftazidime. 
 
ESBL harbouring K. pneumoniae isolates have been found to be resistant to other antibiotics, 
especially, fluroquinolones (Lautenbach et al., 2001) In a study done by Tumbarello et al., in 
Italy, 32% of ESBL producing isolates of K. pneumoniae were resistant to ciprofloxacin 
(Tumbarello et al., 2006). Considering our bacterial samples as pathogenic, at all the occasions 
where ciprofloxacin resistance was present  (Table 5), it co-existed with phenotypic β-lactam 
antibiotics resistance (E. coli: 4, K. pneumoniae: 4, A. baumannii:11 isolates). 
 
Another aspect to consider is the co-existence of carbapenem and aminoglycoside resistance 
phenotype in 91% of A. baumannii isolates in our study ( 
Figure 7), which is confirmed by another study done on multidrug-resistant clinical isolates of 
A. baumannii from Krakow, Poland, where genes conferring resistance to carbapenems and 
aminoglycosides coexisted in 44.3% (61 isolates) clinical strains of A. baumannii (Nowak et 
al., 2014). 
 
Seventeen SHV variants are exclusively found in clinical K. pneumoniae: blaSHV-6, blaSHV-
13, blaSHV-16, blaSHV-18, blaSHV-23, blaSHV-45, blaSHV-64, blaSHV-66, blaSHV-86, 
blaSHV-90, blaSHV-91, blaSHV-98, blaSHV-99, blaSHV-100, blaSHV−104, blaSHV-105, 
and blaSHV-134 (Liakopoulos et al., 2016). These variants are mostly associated with 
plasmids. All these variants were found in our data also (supplementary file 1). A variant 
blaSHV-27 has been detected on different plasmids in E. coli and K. pneumoniae (Corkill et 
al., 2001). In our study, four E. coli isolates, and 26 K. pneumoniae isolates had SHV-27 along 
with plasmids except for two isolates (212, 219). As SHV-27 confers resistance to cefotaxime, 
ceftazidime and aztreonam (Corkill et al., 2001), six K. pneumoniae isolates (211, 212, 213, 
216, 220, 240) from our study had SHV-27 and exhibited resistance to either cefotaxime or 
ceftazidime, or both simultaneously (Table 5). SHV-12 has been reported as the most 
prevalent enzyme within SHV family all over the world in K. pneumoniae and in E. coli from 
community patients (Valverde et al., 2004). In agreement to the statement above, we found 




TEM-1 is the most commonly encountered β-lactamase in gram-negative bacteria. Up to 90% 
of ampicillin resistance in E. coli is due to the production of TEM-1 (Livermore, 1995). 
Regarding TEM-1 in our study, there isolates of E. coli (21), K. pneumoniae (9), and A. 
baumannii (https://www.454.com/.) with the variant (supplementary file 1). TEM-3 and TEM-
4 also seem to be widespread, and to be associated with different clones of  K. pneumoniae in 
ICUs (Asensio et al., 2000). TEM-52  is also widespread in Europe, and is associated with E. 
coli from urinary tract infections (Caccamo et al., 2006). It was also seen in our study that 
TEM-3 and TEM-52 was represented by isolates of E. coli (20), K. pneumoniae (8), and A. 
baumannii (https://www.454.com/.) respectively.  
 
CTX-M-15 prevalence has been increasing all over Europe (Livermore et al., 2007). 
Moreover, we found CTX-M-15 only in four K. pneumoniae isolates (215, 216, 220, 213) 
(Table 5). International spread of blaCTX-M-15 seems to be linked with IncFII plasmids 
(Lavollay et al., 2006), and we observed the presence of both of them together on two 
occasions in our study (213, 216) although not on common nodes. Similarly, blaCTX-M-32, 
which has association with IncN plasmids (Cottell et al., 2013), was present in three isolates 
(213, 216, 220), but its presence with IncN plasmids was not seen.  Another variant blaCTX-
M-9, which is associated with IncHI2 (Novais et al., 2006), was present in two isolates (146, 
147)  along IncHI2 plasmid. blaCTX-M-1 is the most often identified gene on IncI plasmid 
(Rozwandowicz et al., 2018), but it was not found in any of the isolates in our study.  
5.5 Plasmid mediated Resistance 
Overall, the presence of the different types of plasmid Col and IncFIB in the isolates which 
expressed phenotypic resistance to β-lactam antibiotics (33 and 39 isolates) (ampicillin, 
cefotaxime, ceftazidime, meropenem) and trimethoprim (14 and 15 isolates) was observed 
(Table 5). Moreover,  IncFII (different types) were also found in the isolates that expressed 
phenotypic resistance to β- lactam antibiotics (30 isolates). 
 
The most frequently described resistance genes on IncF plasmids are related to 
carbapenemases, aminoglycoside and plasmid-mediated quinolone resistance (PMQR) genes 
(Rozwandowicz et al., 2018). In our study, in all the isolates, where aac/aph and qnr resistance 
genes were present in E.coli and K. pneumoniae, IncF (different types) plasmids were also 
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present, while regarding carbapenemases, it was not observed in A. baumannii isolates, which 
could be due to the low instances of carbapenamases in Norway. 
 
In silico detection using PlasmidFinder and ResFinder on WGS data explores the opportunity 
to associate replicons with antimicrobial resistance genes on the same DNA fragment because 
the exact position of genes and the plasmids is available in these tools.  However,  uncertainty 
prevails in deciding whether genetic elements, which have been identified on different contigs, 
are located on the same plasmid too (Carattoli et al., 2014). Our plasmid detection results had 
only a few instances (E.coli: 11, K. pneumoniae: 1), where the resistance genes and the 
plasmids actually shared the same contig (Table 6 and Figure 15). Moreover, the plasmids 
detected by PLSDB and Brooks et.al were numerous in number and types (80-90 thousand 
hits per isolate before filtering). However, regardless of employed algorithm for plasmid 
detection and identification, there were multiple plasmids found on the same contig that made 
the selection of one confirmed plasmid difficult. This problem can be explained with the fact 
that if the plasmids are sequenced along the rest of the genome, they can rarely be completely 
assembled from Illumina reads, making it difficult to separate the contigs of the plasmids from 
the rest of the genome (Page et al., 2018a). A helpful thing in this regard was to use mlPlasmids 
to confirm the plasmid containing contigs with plasmid databases used (supplementary file 7).  
 
Usually, if the same contig or set of contigs match several plasmids, we can select the plasmid 
that matches over the greatest length of the plasmid with the highest sequence identity (Hall, 
2018). In our case however, the several plasmids with the same assigned contig had identical 
matched plasmid length and identity, which lowered the certainty in identifying plasmids. 
Otherwise, the resistance genes can actually be present on the chromosome and not on the 
plasmid. These two factors contributed to low number of isolates with plasmid mediated 
resistance. 
 
WGS based in silico analysis of resistance genes and their plasmid context is performed in a 
unified way on a large number of isolates (Carrër et al., 2010). However, Plasmid detection 
from WGS can be challenging to understand considering the presence of multiple plasmids or 





6. Conclusion  
In conclusion, detected ESBLs and their resistance specific variants confirm the importance 
of selected pathogens in the spread of antimicrobial resistance in Norway. TEM, SHV, and 
OXA remain the most dominant ESBLs in our study. A total of 63 isolates (57%) had 
concordance between antibiotic resistance phenotype and corresponding resistance genes (to 
keep the analysis brief, only CARD  detected genes were taken), which explains how well 
curated databases ensure a high concordance between phenotype and genotype resistance. 
CARD, ResFinder, and MEGARes performance in resistance gene detection was in agreement 
with each other, and thus reliable. There is however, a significant need for standardization of 
pipelines and databases as well as phenotypic predictions based on the genomic data. 
 
IncFIB, IncFII, and Col remain the dominant types of incompatibility groups of plasmids in 
Enterobacteriaceae isolates. PlasmidFinder was not only more accurate in plasmid detection 
than PLSDB and Brooks et al database, but it also predicted most number of plasmids that 
were hosting antibiotic resistance genes. This happened due to the noise created by huge 
number of hits and the presence of multiple plasmids on the same contig in PLSDB and Brooks 
et al database. Since such contigs were excluded from the plasmid detection analysis, it 
impacted their plasmid mediated resistance analysis.   
 
Important conclusion is that Norway has low level of resistance based on the AMR genes and 
AST data, which is good for the health care in Norway. This could also be attributed to the 
regulations and guidelines for antibiotic use in Norway.  
 
The wide adoption of WGS  has proved to be useful in describing AMR genes and plasmids 
in priority pathogens; E.coli, K. pneumoniae, and A. baumannii in Noway. 
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7. Future Prospects 
In future studies, choice of  hybrid assemblies with the inclusion of non-Norwegian isolates 
can be explored to detect the plasmids with high, comparable certainty in less fragmented 
assemblies. The predicted resistance determinants and the related risks for human health using 
WGS technology should play an important part in future risk assessment policies to combat 
AMR spread in Norway.  
 
This study can be extended to investigate the resistance mechanisms used by antimicrobial 
determinants to identify the correct antibiotic treatment. Moreover, molecular extraction of 
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9.1 Appendix A 
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Figure 17 : Graphical Representation of the effect of sequencing depth on the genotype resistance 
detection of the isolates. The red colored dots represent the isolates with  phenotypic resistance without 
any resistance genes. Two E. coli  and ten K. pneumoniae isolates displayed phenotypic resistance 












































9.3 Appendix C 
 
(Note for supplementary file 5) 
 
Genome annotation with Prokka Genome size of isolates (142, 233, 112, 119 , 131, 
150, 105, 140, 234, 222, 236, 230, 231, 235, , 200, 215, 223, 232) fell into either 
below 2 Mbp or above 6 Mbp (156, 157, 141, 136,  220, 225, 241, 243, 307, 302, 
304). A few isolates had genes below 2000 (142, 112, 119, 131, 105, 150, 233, 142, 
234, 236, 222, 230, 231, 235, 200, 215, 223) or above 6000 (141, 136, 157, 204, 225, 

























































































































9.5 Appendix E 
Table 8: Concordance between phenotype and genotype for predictions made using a database of 






9.6 Supplementary Files 
 
1. S1- Gene variants and nodes CARD/ResFinder 
Description: Gene variants along with nodes, gene length and identity from CARD 
and ResFinder. Details of MEGARes AMRFinder and Prokka are also included. 
 
2. S2- Plasmid detection in silico 
Description: Includes WGS for PlasmidFinder detection and PlasFlow segregated 
WGS probed by Brooks et al and PLSDB for plasmids 
 
3. S3- Plasmidspades assemblies for plasmid detection 
Description: WGS assembled with PlasmidSPAdes and probed through PLSDB, 
Brooks et al and PlasmidFInder 
 
4. S4- Quast statistics for SPAdes assemblies 
Description: SPAdes assemblies evaluated with QUAST for assembly quality 
 
5. S5- Prokka stats supplementary file 
Description: Genomic feature annotation with Prokka 
 
6. S6- Sequencing coverage  
Description: Sequencing coverage for all the isolates 
 
7. S7- mlplasmid predictions 
Description: Plasmid contig prediction through probability value  
8. S8-AMR database 18 Sep 2020 comparison 
Description: Describes AMR database performance evaluation for AMR deection 
9. S9- AMR database comparison supplementary file 
Description: CARD, ResFinder, MEGARes, AMRFinder, Prokka comparison 
10. S10- Trimming data 
Description: Input reads and surviving reads comparison 
11. S11- After trimming sequence quality 
Description: FASTQC  
  
